Inventor · disambiguated record
Mark Jean Gnoth
Also filed as: GNOTH MARK · GNOTH MARK JEAN
27 granted patents·21 pending applications·155 citations·filing 2004–2019
95Inventor score
Top patents by PatentIndex Score
48 records- 0194US9284319B2Heterocyclyl aminoimidazopyridazinesEIS KNUT·Filed 2012·Granted Mar 15, 2016·28 cites·5 claims
- 0292US9320737B2Substituted imidazopyridazinesBAYER IP GMBH·Filed 2012·Granted Apr 26, 2016·27 cites·12 claims
- 0390US9730929B2Substituted aminoimidazopyridazinesEIS KNUT·Filed 2012·Granted Aug 15, 2017·25 cites·14 claims
- 0488US8119663B2Heteroaryl-substituted piperidinesHEIMBACH DIRK·Filed 2008·Granted Feb 21, 2012·16 cites·8 claims
- 0584US9434731B2Imidazo-, pyrazolopyrazines and imidazotriazines and their useBAYER IP GMBH·Filed 2013·Granted Sep 6, 2016·8 cites·3 claims
- 0684US8273752B2Substituted imidazopyrimidines and triazolopyrimidinesSIEGEL STEPHAN·Filed 2008·Granted Sep 25, 2012·11 cites·5 claims
- 0783US8916557B2Substituted 4-Aryl-N-phenyl-1,3,5-triazin-2-aminesLücking Ulrich·Filed 2012·Granted Dec 23, 2014·4 cites·15 claims
- 0881US9029406B2N-carboxyalkylauristatins and use thereofLERCHEN HANS-GEORG·Filed 2012·Granted May 12, 2015·6 cites·13 claims
- 0979US8198267B2Substituted oxazolidinones and their useALLERHEILIGEN SWEN·Filed 2008·Granted Jun 12, 2012·7 cites·8 claims
- 1078US10266548B2Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseasesBAYER IP GMBH·Filed 2017·Granted Apr 23, 2019·2 cites·2 claims
- 1178US9643953B2Substituted benzylpyrazolesBAYER IP GMBH·Filed 2012·Granted May 9, 2017·5 cites·10 claims
- 1275US9669034B24-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine groupLücking Ulrich·Filed 2012·Granted Jun 6, 2017·2 cites·12 claims
- 1374US9499547B2Amino-substituted imidazopyridazinesEIS KNUT·Filed 2012·Granted Nov 22, 2016·3 cites·16 claims
- 1474US8987248B2Substituted piperidines as Par-1 antagonistsJESKE MARIO·Filed 2010·Granted Mar 24, 2015·1 cites·9 claims
- 1574US8084469B2Substituted piperidinesHEIMBACH DIRK·Filed 2010·Granted Dec 27, 2011·3 cites·17 claims
- 1672US8329716B2Hetaryloxy-substituted phenylamino pyrimidines as Rho kinase inhibitorsSCHIROK HARTMUT·Filed 2005·Granted Dec 11, 2012·2 cites·8 claims
- 1772US8202862B2Substituted piperidinesHEIMBACH DIRK·Filed 2010·Granted Jun 19, 2012·2 cites·27 claims
- 1871US8383822B2Substituted oxazolidinones and their useBAYER IP GMBH·Filed 2008·Granted Feb 26, 2013·1 cites·11 claims
- 1970US8436003B2Substituted imidazo- and triazolopyrimidines, imidazo- and pyrazolopyrazines and imidazotriazinesSIEGEL STEPHAN·Filed 2009·Granted May 7, 2013·1 cites·7 claims
- 2068US8664246B2Substituted pyridines, and use thereof as GSK3 inhibitorsSIEGEL STEPHAN·Filed 2009·Granted Mar 4, 2014·1 cites·8 claims
- 2164US10604532B2Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperproliferative diseasesBAYER IP GMBH·Filed 2019·Granted Mar 31, 2020·0 cites·6 claims
- 2255US8476267B2Imidazo-, pyrazolopyrazines and imidazotriazines and their useSIEGEL STEPHAN·Filed 2008·Granted Jul 2, 2013·0 cites·7 claims
- 2354US2013252948A1Substituted piperidinesBAYER IP GMBH·Filed 2013·Application pending·0 cites
- 2453US8487111B2Substituted oxazolidinones and their useALLERHEILIGEN SWEN·Filed 2008·Granted Jul 16, 2013·0 cites·8 claims
- 2553US2017275267A1Substituted cycloalkenopyrazoles as bub1 inhibitors for the treatment of cancerBayer Pharma AG·Filed 2017·Application pending·0 cites
- 2652US2014249133A1Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseasesBAYER IP GMBH·Filed 2012·Application pending·0 cites
- 2750US2015183773A1Substituted piperidinesBayer Pharma AG·Filed 2015·Application pending·0 cites
- 2850US2011034467A1Dihydro-pyrrolopyridine-, dihydro-pyrrolopyridazine- and dihydro-pyrrolopyrimidine-derivatives and use thereofROEHRIG SUSANNE·Filed 2007·Application pending·0 cites
- 2949US8846934B2Substituted oxazolidinones and their useBAYER IP GMBH·Filed 2013·Granted Sep 30, 2014·0 cites·9 claims
- 3049US8440657B2Substituted piperidinesHEIMBACH DIRK·Filed 2010·Granted May 14, 2013·0 cites·23 claims
- 3149US2009258877A1Triazolotriazines and triazolopyrazines and their useBAYER HEALTHCARE AG·Filed 2008·Application pending·0 cites
- 3248US9962389B24-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine groupBAYER IP GMBH·Filed 2017·Granted May 8, 2018·0 cites·15 claims
- 3348US2015141372A1Substituted cycloalkenopyrazoles as bub1 inhibitors for the treatment of cancerBayer Pharma AG·Filed 2013·Application pending·0 cites
- 3448US2010273789A1Aminoacyl prodrugsBAYER SCHERING PHARMA AG·Filed 2008·Application pending·0 cites
- 3548US2011172232A1Aminoacyl prodrugs as an active pharmaceutical ingredient for thromboembolic disordersBAYERS SCHERING PHARMA AG·Filed 2008·Application pending·0 cites
- 3648US2013296343A1Substituted imidazo- and triazolopyrimidines, imidazo- and pyrazolopyrazines and imidazotriazinesBAYER IP GMBH·Filed 2013·Application pending·0 cites
- 3747US9051323B2Substituted imidazopyrimidines and triazolopyrimidinesSIEGEL STEPHAN·Filed 2012·Granted Jun 9, 2015·0 cites·6 claims
- 3847US2010105663A12-(heteroaryl) alkyl indazole 6-phenyl and thienyl methyl amide as thrombin inhibitorsBAYER HEALTHCARE AG·Filed 2007·Application pending·0 cites
- 3946US2008249105A1Pyrrolopyridine-Substituted Benzol Derivatives for Treating Cardiovascular DiseasesBAYER HEALTHCARE AG·Filed 2004·Application pending·0 cites
- 4046US2016318866A1Substituted bipiperidinyl derivativesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 4146US2010010060A1Isoindolin-1-One-, Isoindolin-3-One- and Isoindolin-1,3-Dione-Derivatives and Use ThereofBAYER HEALTHCARE AG·Filed 2007·Application pending·0 cites
- 4245US2012214788A1Heteroaryl-substituted piperidinesHEIMBACH DIRK·Filed 2012·Application pending·0 cites
- 4342US2014050743A1Binding proteins to inhibitors of coagulation factorsDITTMER FRANK·Filed 2012·Application pending·0 cites
- 4441US2012220563A1Substituted piperidinesHEIMBACH DIRK·Filed 2010·Application pending·0 cites
- 4540US2014357655A1Spiroindoline derivatives as gonadotropin- releasing hormone receptor antagonistsBAYER IP GMBH·Filed 2013·Application pending·0 cites
- 4639US2014288069A1Amino-substituted imidazopyridazines as mknk1 kinase inhibitorsEIS KNUT·Filed 2012·Application pending·0 cites
- 4735US2012149694A1Substituted piperidinesHEIMBACH DIRK·Filed 2010·Application pending·0 cites
- 4835US2012129831A1Substituted 3-(1,2,4-Oxadiazol-5-yl)-5-PhenylpiperidinesHEIMBACH DIRK·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Jean Gnoth files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →